Literature DB >> 24140559

Vertical transmission of hepatitis C virus: a tale of multiple outcomes.

Alejandro Escobar-Gutiérrez1, Hugo Soudeyns, Ariane Larouche, Juan Carlos Carpio-Pedroza, Armando Martinez-Guarneros, Carlos A Vazquez-Chacon, Salvador Fonseca-Coronado, Lilian H T Yamasaki, Karina Ruiz-Tovar, Mayra Cruz-Rivera.   

Abstract

Globally, hepatitis C virus (HCV) infection affects approximately 130 million people and 3 million new infections occur annually. HCV is also recognized as an important cause of chronic liver disease in children. The absence of proofreading properties of the HCV RNA polymerase leads to a highly error prone replication process, allowing HCV to escape host immune response. The adaptive nature of HCV evolution dictates the outcome of the disease in many ways. Here, we investigated the molecular evolution of HCV in three unrelated children who acquired chronic HCV infection as a result of mother-to-child transmission, two of whom were also coinfected with HIV-1. The persistence of discrete HCV variants and their population structure were assessed using median joining network and Bayesian approaches. While patterns of viral evolution clearly differed between subjects, immune system dysfunction related to HIV coinfection or persistent HCV seronegativity stand as potential mechanisms to explain the lack of molecular evolution observed in these three cases. In contrast, treatment of HCV infection with PegIFN, which did not lead to sustained virologic responses in all 3 cases, was not associated with commensurate variations in the complexity of the variant spectrum. Finally, the differences in the degree of divergence suggest that the mode of transmission of the virus was not the main factor driving viral evolution.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hepatitis C virus; Molecular evolution; Vertical transmission

Mesh:

Substances:

Year:  2013        PMID: 24140559      PMCID: PMC5042690          DOI: 10.1016/j.meegid.2013.10.005

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  38 in total

1.  Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women.

Authors:  D Conte; M Fraquelli; D Prati; A Colucci; E Minola
Journal:  Hepatology       Date:  2000-03       Impact factor: 17.425

Review 2.  Hepatitis B and C viruses in infants and young children.

Authors:  May K Slowik; Ravi Jhaveri
Journal:  Semin Pediatr Infect Dis       Date:  2005-10

3.  Vertical transmission of hepatitis C virus in a cohort of 2,447 HIV-seronegative pregnant women: a 24-month prospective study.

Authors:  O Ceci; M Margiotta; F Marello; R Francavilla; P Loizzi; A Francavilla; A Mautone; L Impedovo; E Ierardi; M Mastroianni; S Bettocchi; L Selvaggi
Journal:  J Pediatr Gastroenterol Nutr       Date:  2001-11       Impact factor: 2.839

4.  Persistence rate and progression of vertically acquired hepatitis C infection. European Paediatric Hepatitis C Virus Infection.

Authors:  P A Tovo; L J Pembrey; M L Newell
Journal:  J Infect Dis       Date:  2000-02       Impact factor: 5.226

5.  Dynamic coinfection with multiple viral subtypes in acute hepatitis C.

Authors:  Jennifer A Smith; Judith H Aberle; Vicki M Fleming; Peter Ferenci; Emma C Thomson; Peter Karayiannis; Angela R McLean; Heidemarie Holzmann; Paul Klenerman
Journal:  J Infect Dis       Date:  2010-11-10       Impact factor: 5.226

6.  The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies.

Authors:  P Farci; A Shimoda; A Coiana; G Diaz; G Peddis; J C Melpolder; A Strazzera; D Y Chien; S J Munoz; A Balestrieri; R H Purcell; H J Alter
Journal:  Science       Date:  2000-04-14       Impact factor: 47.728

7.  MAFFT multiple sequence alignment software version 7: improvements in performance and usability.

Authors:  Kazutaka Katoh; Daron M Standley
Journal:  Mol Biol Evol       Date:  2013-01-16       Impact factor: 16.240

8.  Hepatitis C virus-specific immune responses and quasi-species variability at baseline are associated with nonresponse to antiviral therapy during advanced hepatitis C.

Authors:  Chihiro Morishima; Stephen J Polyak; Ranjit Ray; Michael C Doherty; Adrian M Di Bisceglie; Peter F Malet; Herbert L Bonkovsky; Daniel G Sullivan; David R Gretch; Alan L Rothman; Margaret James Koziel; Karen L Lindsay
Journal:  J Infect Dis       Date:  2006-02-22       Impact factor: 5.226

Review 9.  Epidemiology of hepatitis C virus infection.

Authors:  Miriam J Alter
Journal:  World J Gastroenterol       Date:  2007-05-07       Impact factor: 5.742

10.  Differing patterns of liver disease progression and hepatitis C virus (HCV) quasispecies evolution in children vertically coinfected with HCV and human immunodeficiency virus type 1.

Authors:  Sophie Canobio; Cynthia M Guilbert; Myriam Troesch; Johanne Samson; Mireille Lemay; Veronique Anne Pelletier; Anne-Claude Bernard-Bonnin; Rafal Kozielski; Normand Lapointe; Steven R Martin; Hugo Soudeyns
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

View more
  3 in total

1.  Vertical Transmission of Hepatitis C Virus: Variable Transmission Bottleneck and Evidence of Midgestation In Utero Infection.

Authors:  Sébastien Fauteux-Daniel; Ariane Larouche; Virginie Calderon; Jonathan Boulais; Chanel Béland; Doris G Ransy; Marc Boucher; Valérie Lamarre; Normand Lapointe; Isabelle Boucoiran; Armelle Le Campion; Hugo Soudeyns
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

Review 2.  Hepatitis C virus molecular evolution: transmission, disease progression and antiviral therapy.

Authors:  Maria Victoria Preciado; Pamela Valva; Alejandro Escobar-Gutierrez; Paula Rahal; Karina Ruiz-Tovar; Lilian Yamasaki; Carlos Vazquez-Chacon; Armando Martinez-Guarneros; Juan Carlos Carpio-Pedroza; Salvador Fonseca-Coronado; Mayra Cruz-Rivera
Journal:  World J Gastroenterol       Date:  2014-11-21       Impact factor: 5.742

Review 3.  Advanced molecular surveillance of hepatitis C virus.

Authors:  Livia Maria Gonçalves Rossi; Alejandro Escobar-Gutierrez; Paula Rahal
Journal:  Viruses       Date:  2015-03-13       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.